S Milutinović, D Breyer, M Janković, A Stefović, V Molnar, V Mrzljak, B Rocić
{"title":"血液透析改善尿毒症患者胰岛素与红细胞胰岛素受体的结合。","authors":"S Milutinović, D Breyer, M Janković, A Stefović, V Molnar, V Mrzljak, B Rocić","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Insulin binding to erythrocytes obtained from uraemic patients was determined using a radioreceptor assay. The binding was reduced by 50 per cent in 20 non-diabetic uraemic patients in comparison with 20 controls (4.7 +/- 1.79 vs 9.37 +/- 1.30 (mean +/- SD) p less than 0.01). During the course of haemodialysis insulin binding steadily increased in a time dependent manner in proportion to the efficiency of haemodialysis as assessed by relative decrease in plasma urea, uric acid or creatinine. Incubation of healthy donors' erythrocytes with uraemic plasma resulted in a dose dependent inhibition of insulin binding with a maximum of 40 per cent. These data indicate the presence of dialysable inhibitors of insulin binding in uraemic plasma.</p>","PeriodicalId":76354,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association","volume":"19 ","pages":"763-8"},"PeriodicalIF":0.0000,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.\",\"authors\":\"S Milutinović, D Breyer, M Janković, A Stefović, V Molnar, V Mrzljak, B Rocić\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Insulin binding to erythrocytes obtained from uraemic patients was determined using a radioreceptor assay. The binding was reduced by 50 per cent in 20 non-diabetic uraemic patients in comparison with 20 controls (4.7 +/- 1.79 vs 9.37 +/- 1.30 (mean +/- SD) p less than 0.01). During the course of haemodialysis insulin binding steadily increased in a time dependent manner in proportion to the efficiency of haemodialysis as assessed by relative decrease in plasma urea, uric acid or creatinine. Incubation of healthy donors' erythrocytes with uraemic plasma resulted in a dose dependent inhibition of insulin binding with a maximum of 40 per cent. These data indicate the presence of dialysable inhibitors of insulin binding in uraemic plasma.</p>\",\"PeriodicalId\":76354,\"journal\":{\"name\":\"Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association\",\"volume\":\"19 \",\"pages\":\"763-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1983-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
胰岛素与尿毒症患者红细胞的结合是用放射受体测定法测定的。20名非糖尿病尿毒症患者与20名对照组相比,结合减少了50% (4.7 +/- 1.79 vs 9.37 +/- 1.30(平均+/- SD) p < 0.01)。在血液透析过程中,胰岛素结合以时间依赖的方式与血液透析的效率成比例地增加,通过血浆尿素、尿酸或肌酐的相对下降来评估。健康供者红细胞与尿毒症血浆孵育导致胰岛素结合的剂量依赖性抑制,最大抑制率为40%。这些数据表明尿毒症血浆中存在可透析的胰岛素结合抑制剂。
Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
Insulin binding to erythrocytes obtained from uraemic patients was determined using a radioreceptor assay. The binding was reduced by 50 per cent in 20 non-diabetic uraemic patients in comparison with 20 controls (4.7 +/- 1.79 vs 9.37 +/- 1.30 (mean +/- SD) p less than 0.01). During the course of haemodialysis insulin binding steadily increased in a time dependent manner in proportion to the efficiency of haemodialysis as assessed by relative decrease in plasma urea, uric acid or creatinine. Incubation of healthy donors' erythrocytes with uraemic plasma resulted in a dose dependent inhibition of insulin binding with a maximum of 40 per cent. These data indicate the presence of dialysable inhibitors of insulin binding in uraemic plasma.